Trial intelligence / Profile preview

Phase 1 first-in-human FLX475 single- and multiple-ascending-dose, placebo-controlled study in healthy volunteers

NL-OMON44307Phase 1Active, not recruiting

Sponsor

FLX Bio, Inc.

Start

Nov 2017

Modality

Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1